Your browser is no longer supported. Please, upgrade your browser.
ANGO [NASD]
AngioDynamics, Inc.
Index- P/E- EPS (ttm)-4.44 Insider Own0.70% Shs Outstand38.36M Perf Week-6.09%
Market Cap876.63M Forward P/E316.85 EPS next Y0.07 Insider Trans-3.63% Shs Float36.75M Perf Month-2.69%
Income-169.10M PEG- EPS next Q-0.00 Inst Own95.10% Short Float2.66% Perf Quarter9.83%
Sales272.50M P/S3.22 EPS this Y-44.40% Inst Trans-0.31% Short Ratio3.41 Perf Half Y103.79%
Book/sh11.86 P/B1.95 EPS next Y55.32% ROA-28.80% Target Price25.50 Perf Year115.56%
Cash/sh1.44 P/C16.08 EPS next 5Y15.00% ROE-37.20% 52W Range8.05 - 25.25 Perf YTD50.88%
Dividend- P/FCF89.45 EPS past 5Y4.38% ROI-33.50% 52W High-7.80% Beta0.82
Dividend %- Quick Ratio1.90 Sales past 5Y-5.80% Gross Margin53.10% 52W Low189.19% ATR0.81
Employees800 Current Ratio2.90 Sales Q/Q2.00% Oper. Margin-62.50% RSI (14)45.81 Volatility3.57% 3.35%
OptionableYes Debt/Eq0.00 EPS Q/Q38.50% Profit Margin-62.10% Rel Volume0.46 Prev Close23.13
ShortableYes LT Debt/Eq0.07 EarningsMar 30 BMO Payout- Avg Volume286.48K Price23.28
Recom2.30 SMA20-3.74% SMA501.22% SMA20048.04% Volume110,851 Change0.65%
Nov-25-20Upgrade Raymond James Mkt Perform → Strong Buy $18
Apr-08-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-01-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-05-18Downgrade Craig Hallum Buy → Hold
Apr-07-17Reiterated Cantor Fitzgerald Overweight $20 → $21
Mar-30-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-08-17Initiated Barclays Equal Weight $17
Nov-04-16Initiated Cantor Fitzgerald Buy
Apr-08-16Resumed Piper Jaffray Neutral
Jan-08-16Reiterated Canaccord Genuity Buy $17.50 → $14.50
Nov-10-15Downgrade Raymond James Outperform → Mkt Perform
Jul-24-15Initiated KeyBanc Capital Mkts Overweight
Jun-19-14Upgrade Canaccord Genuity Hold → Buy $16.25 → $20
Oct-09-12Reiterated Canaccord Genuity Hold $14 → $13.50
Jun-25-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
Jul-15-11Upgrade Stifel Nicolaus Hold → Buy $16.50
Jul-15-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
Jun-14-11Downgrade Wedbush Neutral → Underperform $14 → $12
Sep-08-10Reiterated Wedbush Neutral $17.50 → $14
Apr-29-21 11:30AM  
Apr-20-21 12:05PM  
Apr-12-21 08:27AM  
06:00AM  
Apr-05-21 04:01PM  
Mar-31-21 12:59PM  
10:35AM  
04:30AM  
Mar-30-21 11:30AM  
08:15AM  
07:00AM  
06:15AM  
Mar-29-21 10:08AM  
Mar-23-21 12:30PM  
Mar-15-21 04:01PM  
Mar-10-21 08:29AM  
Mar-09-21 04:01PM  
08:00AM  
Mar-05-21 09:04AM  
Mar-04-21 11:06AM  
Mar-03-21 12:42PM  
09:35AM  
Mar-01-21 04:01PM  
11:15AM  
11:11AM  
Feb-26-21 09:26AM  
09:22AM  
09:01AM  
Feb-23-21 11:16PM  
Feb-12-21 11:47AM  
10:38AM  
Feb-11-21 12:24PM  
10:35AM  
09:11AM  
Feb-10-21 11:31AM  
10:18AM  
Feb-09-21 09:59AM  
Feb-08-21 09:14AM  
Feb-06-21 11:30AM  
Feb-05-21 11:09AM  
09:50AM  
06:00AM  
Feb-04-21 12:25PM  
11:25AM  
09:30AM  
09:29AM  
09:22AM  
08:45AM  
08:06AM  
Feb-03-21 10:42AM  
10:30AM  
09:48AM  
08:16AM  
Feb-02-21 01:11PM  
09:39AM  
08:45AM  
08:35AM  
Feb-01-21 08:00AM  
Jan-29-21 07:22AM  
Jan-21-21 11:32AM  
Jan-15-21 12:00PM  
Jan-12-21 12:00PM  
Jan-10-21 01:03AM  
Jan-08-21 12:42PM  
07:25AM  
Jan-07-21 11:30AM  
08:15AM  
07:17AM  
07:00AM  
06:15AM  
Jan-06-21 10:14AM  
Jan-04-21 04:01PM  
Dec-29-20 04:01PM  
Dec-21-20 11:41PM  
Dec-12-20 07:25PM  
Dec-09-20 04:01PM  
Nov-26-20 08:58AM  
Nov-25-20 07:47AM  
07:44AM  
Nov-17-20 08:48AM  
Nov-12-20 09:00AM  
08:39AM  
Nov-11-20 06:11AM  
Nov-10-20 04:46PM  
08:45AM  
08:07AM  
Nov-09-20 10:02AM  
08:09AM  
Nov-06-20 09:01AM  
08:09AM  
08:07AM  
Nov-05-20 10:41AM  
10:40AM  
10:07AM  
09:56AM  
09:55AM  
09:51AM  
09:49AM  
09:13AM  
Nov-04-20 08:39AM  
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trowbridge Stephen AEVP and CFOApr 15Option Exercise14.0713,625191,70473,371Apr 16 05:39 PM
Helsel DaveSVP Global Operations and R&DApr 14Sale23.933,50083,75519,115Apr 15 04:20 PM
DONNELLY HOWARD WDirectorApr 01Option Exercise14.645,72683,82996,595Apr 05 05:53 PM
JOHNSON WESLEYDirectorJan 20Sale18.536,500120,44577,911Jan 21 10:15 AM
Trowbridge Stephen AEVP and CFOAug 11Buy9.381,0139,50260,273Aug 12 04:14 PM
Clemmer James CPresident and CEOJul 31Buy8.2640,000330,400343,319Aug 03 05:27 PM